Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

The Regeneron litigation highlights that donations routed through independent entities are not immune from challenge, especially if the government believes they are effectively covering a patient’s co ...

President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States.

H1 sales growth for Novo Nordisk’s segment that includes Ozempic and Wegovy was down from the same period in 2024.

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...

Donald Trump plans to impose new tariffs on pharmaceuticals and semiconductors to boost manufacturing in the US.

The US government has long sought to shift pharmaceutical manufacturing back to domestic soil, citing both economic and ...

The Trump administration says it's aiming to lower drug costs for Americans. It's given drug companies 60 days to lower ...

The US president is angry Americans pay more for medicine than citizens of other countries. Will he want the PBS to help ...